الدراسات

دراسات الإصدار التاسع 4 سبتمبر 2026 (إصدار خاص) من المجلة الدولية للعلوم والتكنولوجيا

Evaluation of Biofilm Formation and Carbapenemase-Encoding Genes in Clinical A.baumannii Isolates

  BASIMA MUHAMMED HAMZA AL.DUHAIMI (1) Ameer.B.A(2) Hala Hammadi,(3) Abstract : Background: Carbapenems, a class of beta-lactam antibiotics, are commonly used to treat multi-drug-resistant Acinetobacter baumannii isolates. Objective: This study aimed to detecting Carbapenem-resistant gene and biofilm formation in Acinetobacter baumannii Materials and Methods: From January – June 2024, 300 specimens were collected from Al-Hilla

قراءة وتحميل الدراسة »

Estimation of pulpitis prevevelance in permenant dentition with incomplete rootcanal

Dina Saad D.r\ Mohammed Ejresh Abstract : ​​​​​​​​​​​​​Background: Pulpitis in immature permanent teeth presents a significant clinical challenge because incomplete root development, wide dentinal tubules, and an open apical foramen may influence disease progression, diagnosis, and treatment selection. Early recognition of pulpal disease is important to preserve tooth vitality and allow continued root maturation. Objective:

قراءة وتحميل الدراسة »

Evaluation Of Efficacy Of Fluoride On Enamel Surface Microstructure Of Avulsed Tooth After Storage On The bovine Milk (An in Vitro Study)

Rawaa Sadiq Obeid 1    DR. Mohammed  Abdulla Ejresh 2  Israa Abdul Al Sattar Hamza 3 Abstract : ​​​​​​​​​Background: Dental avulsion is a severe traumatic dental injury involving complete displacement of the tooth from its socket. Immediate replantation is preferred, but when this is not possible, proper temporary storage is essential to preserve periodontal ligament

قراءة وتحميل الدراسة »

Efficacy and tolerability of Generic Brivaracetam (Bevanta) on Drug Resistant Epilepsy patients in Babil Neurology Center (A single Center experience)

Salam F. Mohammed Rabeea (1) Mustafa Falah Hamzah Mhail(2)   Mustafa Makki Ajam(3)  Wahab Razaq Ebdan (4) Saif M. T. Algburi(5) Abstract : Background: Brivaracetam (BRV) a third-generation Antiseizure medication (ASM) from a Racetam group structurally related to its predecessor Levetiracetam but has a higher affinity and selectivity to synaptic vesicle protein 2A (SV2A) with

قراءة وتحميل الدراسة »
تواصل عبر الواتساب اتصال هاتفي إرسال إيميل